Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
Green MM, Chao N, Chhabra S, Corbet K, Gasparetto C, Horwitz A, Li Z, Venkata JK, Long G, Mims A, Rizzieri D, Sarantopoulos S, Stuart R, Sung AD, Sullivan KM, Costa L, Horwitz M, Kang Y. Green MM, et al. J Hematol Oncol. 2016 Aug 17;9(1):71. doi: 10.1186/s13045-016-0301-2. J Hematol Oncol. 2016. PMID: 27535663 Free PMC article. Clinical Trial.
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.
Sivaraj D, Green MM, Li Z, Sung AD, Sarantopoulos S, Kang Y, Long GD, Horwitz ME, Lopez RD, Sullivan KM, Rizzieri DA, Chao NJ, Gasparetto C. Sivaraj D, et al. Among authors: green mm. Biol Blood Marrow Transplant. 2017 Feb;23(2):262-268. doi: 10.1016/j.bbmt.2016.11.010. Epub 2016 Nov 14. Biol Blood Marrow Transplant. 2017. PMID: 27856369 Free PMC article.
Panobinostat for the management of multiple myeloma.
Sivaraj D, Green MM, Gasparetto C. Sivaraj D, et al. Among authors: green mm. Future Oncol. 2017 Mar;13(6):477-488. doi: 10.2217/fon-2016-0329. Epub 2016 Oct 25. Future Oncol. 2017. PMID: 27776419 Review.
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.
Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Palmer J, Chen GL, Jagasia MH, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM, Martin PJ, Sarantopoulos S, Lee SJ, Flowers ME. Arai S, et al. Clin Cancer Res. 2016 Jan 15;22(2):319-27. doi: 10.1158/1078-0432.CCR-15-1443. Epub 2015 Sep 16. Clin Cancer Res. 2016. PMID: 26378033 Free PMC article. Clinical Trial.
Solvation Environment and Interface Dynamics of Li2B12H12 and Li2B12F12 Electrolytes Uncovered by Theory and Operando Optical and FTIR Spectroelectrochemistry.
Simonyan H, Zhong L, Green MM, Movsesyan K, Fraire A, Ward PA, Lau KC, Teprovich JA Jr. Simonyan H, et al. Among authors: green mm. ACS Appl Mater Interfaces. 2024 Dec 18;16(50):70028-70037. doi: 10.1021/acsami.4c14485. Epub 2024 Dec 5. ACS Appl Mater Interfaces. 2024. PMID: 39637410 Free PMC article.
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy.
Hu Y, Revenko A, Barsoumian H, Bertolet G, Fowlkes NW, Maazi H, Green MM, He K, Sezen D, Voss TA, Leyton CSK, Masrorpour F, Rafiq Z, Puebla-Osorio N, Leuschner C, MacLeod R, Cortez MA, Welsh JW. Hu Y, et al. Among authors: green mm. J Exp Clin Cancer Res. 2024 Mar 6;43(1):70. doi: 10.1186/s13046-024-02992-2. J Exp Clin Cancer Res. 2024. PMID: 38443968 Free PMC article.
217 results